OKSANA NICHOLS: Open Payments
NPI 1275827578 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 60 payments from 16 companies in 2025. Trend: 2023 $1,491 · 2024 $1,597 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $279 |
| PFIZER INC. | 12 | $215 |
| Novo Nordisk Inc | 8 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $129 |
| Lilly USA, LLC | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Abbott Laboratories | 3 | $53 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Medtronic, Inc. | 1 | $24 |
Products named: VRAYLAR, CAPLYTA, ELIQUIS, MOUNJARO, NURTEC ODT, QULIPTA, FREESTYLE LIBRE 3, OTEZLA.
Industry payments across NY — which companies pay providers there.
